In this update, we review two recent papers that address the question of people with type 2 diabetes who take metformin living longer than people without the disease who don’t, but without the flaw in the 2014 study. We find that, as expected, metformin is a good diabetes drug but shows no sign of being a longevity therapeutic.
Read more about SRF Education programs highlights and upcoming events.
SENS Research Foundation (SRF) is launching its campaign Sponsor a Student to increase charitable donations that will allow it to hire more student researchers and teach them that aging is not indisputable. Sponsoring a student dramatically transforms a young person’s life, giving them a chance to conduct world-class research and learn more about the career that awaits them.
We are thrilled to announce the launch of a joint PhD program between SENS Research Foundation and the University of Toledo Biological Sciences Department. This program offers a unique opportunity for aspiring researchers to pursue their doctoral degree in the cutting-edge field of anti-aging research, with a damage-repair approach.
TTR cardiac amyloid contributes to heart failure and appears to limit the lives of the longest-lived humans. One AmyloSENS antibody shows high promise to remove this amyloid and restore function in the aging heart in an early-stage clinical trial. A second such antibody is coming close behind it, and a tiny number of people’s immune systems appear to generate such antibodies on their own.
June 23, 2023 – SRF had the Grand Opening of our expanded Research Center in Mountain View, CA. In attendance were local and state dignitaries, members of the SRF Board, SRF senior staff and scientific leads, SRF staff and Education program participants, and a number of distinguished and welcome guests.
The Education Department is thrilled to present the 2023 Summer Scholars. Our 12 scholars will be conducting biomedical research to combat diseases of aging in 10 different labs.
SRF has launched a fundraising campaign on experiment.com to fund projects in damage repair research. Find out more about our Research Department’s amazing projects, and be a part of our quest by donating today.
The 2023 application season is coming to a close with a very competitive applicant pool. Read more about highlights and upcoming events.
Scientists at SENS Research Foundation led by Dr. Tesfahun (Tes) Dessale Admasu have just published their exciting new senolytic strategy to destroy a wider range of senescent cells than has up to now been possible.
Sign up to stay informed about the latest news and opportunities with SRF!
Use of this Web site constitutes acceptance of the Terms of Use and Privacy Policy.
© 2023 SENS Research Foundation – ALL RIGHTS RESERVED
